Here's Why Investors Should Hold CNO Financial Stock for Now

CNO Financial Group reported solid operational growth in Q2 2025, with an 8.7% increase in collected premiums and 1.5% growth in insurance policy income, driven by its diversified product portfolio, strategic acquisitions, and technology investments, contributing to a 14.4% stock rise over the past year. However, the company faces significant financial headwinds, including a high long-term debt-to-capital ratio of 60% (nearly double the industry average), a sharp reduction in unrestricted cash to $766 million from $1.7 billion, and escalating insurance policy benefits and expenses, leading to a Zacks Rank #3 (Hold) recommendation.

Analysis

CNO Financial Group presents a mixed financial profile, characterized by strong operational growth juxtaposed with significant balance sheet risks. In Q2 2025, the company reported an 8.7% year-over-year increase in total collected premiums and a 1.5% rise in insurance policy income, fueled by its diversified annuity, life, and health products. This operational momentum, supported by strategic acquisitions and technology investments, has contributed to a 14.4% stock price increase over the past year, outperforming the industry's 6.6% growth. The company also maintains a commitment to shareholder returns, having repurchased $100 million in shares in Q2. However, these positive indicators are tempered by considerable financial headwinds. CNO's long-term debt-to-capital ratio stands at a high 60%, nearly double the industry average of 30.2. This leverage is compounded by a sharp decline in unrestricted cash to $766 million from $1.7 billion at the end of 2024, while long-term debt remains elevated at $3.8 billion. Furthermore, profitability is under pressure from escalating expenses, which surged 12.9% in Q2 2025, causing a 20 basis point deterioration in the expense ratio.

Key Decisions for Investors

• Given the conflict between strong premium growth and a highly leveraged balance sheet, a neutral or 'Hold' stance is appropriate until the company demonstrates improved financial stability.
• Investors should closely monitor CNO's upcoming quarterly reports for any reduction in its debt-to-capital ratio and a stabilization of its cash position, as these are the primary risks currently weighing on the stock.
• Pay close attention to expense management, as the recent 12.9% increase in costs and deteriorating expense ratio could signal further margin compression if not brought under control.
• Consider the stock's forward P/E of 9.50X, which is above the industry average of 8.86X, suggesting the market may be pricing in some operational success but potentially overlooking the balance sheet strain.